CORRECTION article

Front. Immunol., 07 November 2022

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1074864

Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy

  • Department of Nephrology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

In the published article, the funding information was missing. The correct Funding statement appears below.

Funding

This project was funded by the National Key R&D Programme of China (2021YFC2009404); the Science and Technology Projects in Guangzhou (201904010142) and the Natural Science Foundation of Guangdong Province (2021A1515010801).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

IgA nephropathy, Renin-angiotensin system inhibitors, Exosome, Biomarker, Treatment response

Citation

Wu J, Wei X, Li J, Gan Y, Zhang R, Han Q, Liang P, Zeng Y and Yang Q (2022) Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy. Front. Immunol. 13:1074864. doi: 10.3389/fimmu.2022.1074864

Received

20 October 2022

Accepted

21 October 2022

Published

07 November 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland;

Volume

13 - 2022

Updates

Copyright

*Correspondence: Qiongqiong Yang,

†These authors have contributed equally to this work

This article was submitted to Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics